Version October 2024
| Bone marrow toxicity |
| Neutropenia (most common, usually reversible) |
| Thrombocytopenia (dose related, usually reversible) |
| Anemia (rare) |
| Hepatic toxicity |
| Cirrhosis & fibrosis |
| Pulmonary toxicity |
| Opportunistic infections |
| PCP, CMV, herpes zoster, fungal, mycobacterial, etc |
| Noninfectious conditions |
| Hypersensitivity pneumonitis |
| Organizing pneumonia (previously called bronchiolitis obliterans with organizing pneumonia or BOOP) |
| Acute lung injury (noncardiogenic pulmonary edema) |
| Pulmonary fibrosis |
| Asthma/hyperreactive airways disease |
| Pleuritis and/or pleural effusion |
| Miscellaneous |
| Oligospermia |
| Teratogenicity |
| Malignancy |
CMV: cytomegalovirus; PCP: Pneumocystis pneumonia.
* Major adverse effects are defined as potentially life threatening (incidence <1%) or requiring withdrawal of treatment (incidence 3 to 15%).Do you want to add Medilib to your home screen?
